Investors tracking the electrification, grid-modernization, and artificial intelligence (AI) infrastructure buildout frequently weigh specialty contractors against large-scale infrastructure services leaders. This stock comparison puts ECG (Everus Construction Group) side by side with PWR (Quanta Services). Both companies benefit from rising electricity demand and utility capital spending, yet they differ sharply in size, market positioning, valuation, and risk profile. This analysis is relevant for growth-oriented traders evaluating momentum and catalysts, as well as long-term investors assessing which business offers the more durable exposure to secular infrastructure themes. The comparison focuses on relative performance, recent developments, and observable sentiment shifts rather than short-term price calls.
ECG, or Everus Construction Group, is a Bismarck, North Dakota-based specialty contractor spun off from MDU Resources in late 2024. It operates through two segments: Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), serving utilities, manufacturing, commercial, institutional, and renewables customers. Recent quarters have shown strong growth, with second-quarter 2026 revenue up roughly 34% year over year and a backlog of about $4.55 billion, up more than 50%. The company completed a roughly $295 million acquisition of Epsilon to add off-site modular construction and broaden exposure to data centers, advanced manufacturing, and healthcare.
In recent weeks, however, ECG shares have pulled back meaningfully from their 52-week high, reflecting investor caution about integration workloads, uneven E&M demand, and whether elevated EBITDA (earnings before interest, taxes, depreciation, and amortization) margins are sustainable. The stock trades at a comparatively modest P/E multiple, signaling that the market is applying a smaller-company discount to its growth story.
PWR, or Quanta Services, is a Houston-based provider of engineering, construction, and maintenance services for electric transmission, substations, power generation, and large-load facilities. It is among the largest and most diversified players in North American energy infrastructure. Recent results have been strong, with second-quarter 2026 revenue of roughly $9.6 billion and a record backlog of approximately $53 billion, up about 50% year over year. Management raised its full-year outlook, and AI-related data-center work is expected to reach around 18% of revenue by 2026, up from about 10% previously.
Like ECG, PWR has cooled in recent weeks after a powerful run, yet it retains a strong year-to-date return and a five-year total shareholder return exceeding 400%. The consensus analyst rating remains "Strong Buy," though the stock trades at a premium forward P/E that leaves less room for execution missteps.
Tickeron maintains a large catalog of AI trading bots covering thousands of tickers, each with its own trading style, strategy, timeframe, performance record, and universe of securities. Because market conditions change constantly, not every bot fits every environment. That is why Tickeron curates a dedicated Trending AI Robots section, spotlighting the strategies currently best aligned with prevailing market dynamics. These bots vary from short-term swing traders to longer-horizon trend followers, offering a range of statistics and historical performance metrics for review. For traders seeking a systematic, data-driven perspective on names like ECG and PWR, exploring the Trending AI Robots page can provide an additional layer of market insight.
The most immediate contrast is scale. PWR generates tens of billions in annual revenue and commands a backlog roughly twelve times the size of ECG's, giving it deeper customer relationships, a larger self-perform workforce, and broader diversification across transmission, generation, and data-center end markets. ECG, by contrast, offers a more concentrated, higher-beta way to express the same electrification theme, with meaningful exposure to electrical and mechanical work.
On valuation, ECG trades at a much lower P/E multiple, which may appeal to value-conscious investors but also reflects integration risk from its Epsilon acquisition and a shorter public track record. PWR commands a premium multiple justified by record backlog and AI-driven demand, though that leaves it more sensitive to any slowdown in technology capital spending. In terms of momentum, PWR has demonstrated stronger, longer-duration relative performance, while ECG's sharper recent drawdown underscores its higher volatility and smaller float.
Based on observable factors, Tickeron's AI would likely favor PWR at present. Its larger scale, record backlog, consistent earnings beats, stronger analyst consensus, and more durable secular tailwinds around grid modernization and AI power demand point to greater trend consistency and stability. ECG offers faster reported growth and a cheaper valuation, but its smaller capitalization, integration burden, and more volatile recent price action suggest higher uncertainty. This assessment is probabilistic rather than definitive, reflecting current market positioning and momentum rather than a guaranteed outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Be on the lookout for a price bounce soon.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ECG's RSI Indicator exited the oversold zone, 4 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
Following a +11.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECG advanced for three days, in 106 of 124 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
ECG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECG as a result. In 25 of 40 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for ECG turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 13 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
ECG moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ECG crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for ECG entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.059) is normal, around the industry mean (15.143). P/E Ratio (15.382) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (1.335) is also within normal values, averaging (2.886).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. ECG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The RSI Indicator for PWR moved out of oversold territory on October 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In 14 of the 16 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 46 cases where PWR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PWR as a result. In 65 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
Following a +16.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where PWR advanced for three days, in 260 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
PWR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for PWR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 28 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
PWR moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PWR crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.
The 50-day moving average for PWR moved below the 200-day moving average on November 06, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PWR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for PWR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. PWR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.438) is normal, around the industry mean (15.143). P/E Ratio (60.981) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (1.443) is also within normal values, averaging (3.522). Dividend Yield (0.001) settles around the average of (0.215) among similar stocks. P/S Ratio (2.860) is also within normal values, averaging (2.886).
PWR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 24 | |
SMR RATING 1..100 | 56 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ECG | PWR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 88% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 62% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 69% |
| Advances ODDS (%) | 2 days ago 85% | 3 days ago 74% |
| Declines ODDS (%) | 7 days ago 67% | 7 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 68% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ECG’s FA Score shows that 1 FA rating(s) are green while PWR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ECG’s TA Score shows that 4 TA indicator(s) are bullish while PWR’s TA Score has 5 bullish TA indicator(s).
ECG (@Engineering & Construction) experienced а -23.95% price change this week, while PWR (@Engineering & Construction) price change was -11.24% for the same time period.
The average weekly price growth across all stocks in the @Engineering & Construction industry was -6.50%. For the same industry, the average monthly price growth was -12.80%, and the average quarterly price growth was -28.63%.
PWR is expected to report earnings on Feb 25, 2027.
Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
A.I.dvisor indicates that over the last year, ECG has been closely correlated with FIX. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if ECG jumps, then FIX could also see price increases.
| Ticker / NAME | Correlation To ECG | 1D Price Change % | ||
|---|---|---|---|---|
| ECG | 100% | +1.54% | ||
| FIX - ECG | 79% Closely correlated | -0.66% | ||
| EME - ECG | 76% Closely correlated | -1.15% | ||
| PWR - ECG | 75% Closely correlated | -1.41% | ||
| STRL - ECG | 74% Closely correlated | -0.38% | ||
| MYRG - ECG | 68% Closely correlated | -2.31% | ||
More | ||||